| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18544725 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 133 journal articles in the PubMed database | Email to a friend | | |
| Wang NC, Maggioni AP, Konstam MA, et al.
Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. [Journal Article, Research Support, Non-U.S. Gov't]
JAMA 2008 Jun 11; 299(22):2656-66.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Konstam MA, Gheorghiade M, Burnett JC, et al.
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. [Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
JAMA 2007 Mar 28; 297(12):1319-31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Shukla HH, Hellkamp AS, James EA, et al.
Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Heart Rhythm 2005 Mar; 2(3):245-51.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Young JB, Dunlap ME, Pfeffer MA, et al.
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. [Journal Article]
Circulation 2004 Oct 26; 110(17):2618-26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Wilkoff BL, Cook JR, Epstein AE, et al.
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
JAMA 2002 Dec 25; 288(24):3115-23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | O'Meara E, Clayton T, McEntegart MB, et al.
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. [Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Circulation 2007 Jun 19; 115(24):3111-20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gheorghiade M, Gattis WA, O'Connor CM, et al.
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. [Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial]
JAMA 2004 Apr 28; 291(16):1963-71.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hillege HL, Nitsch D, Pfeffer MA, et al.
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. [Journal Article]
Circulation 2006 Feb 7; 113(5):671-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Young JB, Abraham WT, Smith AL, et al.
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
JAMA 2003 May 28; 289(20):2685-94.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
